09Jan
07Jan
EXCLUSIVE: 2025 vision tech trends
Roland Mattern, Director of Sales at eSight by Gentex Corporation, discusses some of the key vision technology trends that will shape 2025 and give people greater independence and inclusivity across various aspects of life. Modern technology continues to change every aspect of human life and vision technology is no different. More than two million people in the UK have some degree of visual impairment or sight loss and nearly half of these people have a long-term, irreversible eye health condition....
04Jan
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
LPOXY Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on innovative therapies for infectious disease prevention, announced today that it has signed a term sheet to acquire selected assets from Xeno Biosciences Inc. The assets include regulatory filings, correspondence, and documentation from FDA and global regulatory interactions, as well as comprehensive CMC data. LPOXY will benefit from ownership of data generated in Xeno's Phase I and Ib clinical trials, which validates the safety of the Active Pharmaceutical Ingredient shared by Xeno's...
04Jan